跳至主要内容
临床试验/IRCT20210125050142N1
IRCT20210125050142N1招募中3 期

Evaluation the effect of the fenugreek hydrolyzed protein on lipids and CRP levels in hypercholesterolemia patients

ational institute for medical research development0 个研究点目标入组 60 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
All

入选标准

  • Patients with low to moderate risk for cardiovascular events
  • LDL 116 -180 mg /d

排除标准

  • Drinking alcohol,
  • Use of effective supplements on blood lipids (such as fish oil), Immunosuppressive drugs, blood lipid-lowering drugs (statins, fibrates, niacin, …)
  • People with hypothyroidism, nephrotic syndrome or renal dysfunction or liver dysfunction
  • People with uncontrolled hypertension (systolic blood pressure greater than 160 or diastolic blood pressure greater than 100 mmHg),
  • History of dizziness and convulsions,
  • Pregnancy or lactation
  • Sensitivity to studied plant

研究者

发起方
ational institute for medical research development

相似试验